Document data lineage
Track sources, transformations and timestamps.
Pharmaceutical data integrity
Pharmaceutical data integrity and traceable approvals
Document revisions, source records and approvals must remain consistent across the systems involved. We define data lineage, validation checks, access responsibilities and controlled exchange between applications.
Where the existing process loses time and reliability
Multiple sources, manual edits and unclear approvals make records difficult to reconstruct through their lifecycle. A new data platform without governance would preserve the underlying problem.
Our approach begins with the process, data provenance and responsible teams. Only then do we choose integration, software, rules or models.
The industry context determines failure consequences and controls. We make no unverified performance claims.
Four operational improvements to engineer
The following requirements work together to address pharmaceutical data integrity and documentation.
Make changes visible
Provide controlled version history and audit information.
Support approvals
Link review states to accountable teams.
Apply quality checks
Validate records and flag discrepancies.
Connecting data, business rules and application logic
Identify authoritative sources, data meanings and approval rules first. Pipelines record transformations and apply quality checks. Business interfaces present approved records for the responsible roles.
The implementation belongs to Valanor's software and data engineering capabilities. Its industry-specific context is explained on the related sector page.
From process issue to a testable pilot
We validate the critical assumptions before considering wider rollout.
Define process boundaries
Select an approved data or document workflow.
Confirm sources and obligations
Review ownership, quality rules and compliance needs.
Implement controlled processing
Develop validations, history and access checks.
Obtain business and quality approval
Validate outcomes with designated owners.
Engineering trade-offs and decision boundaries
Technical implementation alone does not guarantee GxP compliance or regulatory authorization. Required qualification depends on intended use and responsible Quality teams.
Validation compares actual error cases, alternative methods and the operational workflow. Existing systems are retained where they work; custom development is justified by the requirement, not chosen by default.
Prerequisites for reliable implementation
These conditions influence effort, feasibility, risk and the responsibilities of the teams involved.
Source of truth
Define authoritative records and ownership.
Change history
Capture transformations and changes.
Domain approval
Retain clear sign-off responsibilities.
Project-specific review
Determine validation needs for the actual use.
Scope of the engineering example
These are illustrative technical applications, not claimed outcomes from a named customer project. The architecture, data scope and acceptance criteria must be established against the actual process.
For relevant technical capabilities, see Data & AI Engineering or Platform Engineering. The related industry page explains sector-specific considerations.
Industry context
See how this use case fits into the wider industry's software, data and AI needs.
Frequently asked questions: Pharmaceutical data integrity and documentation
Answers to common technical decisions before implementation.
Is the system automatically GxP validated?
No. Validation depends on the intended use and requirements.
Can current software be integrated?
Yes, when interfaces and controls are suitable.
Why does integrity matter?
It enables traceable changes, accountable decisions and reliable reporting.
When is AI appropriate?
Only for scoped tasks with suitable data and human verification.
Discuss a specific process
Which step do you want to improve first?
Tell us about the process, participating systems and intended results. Aleksandar Basara can review the technical starting point and validation steps with you.
Aleksandar Basara
Managing Director
aleks@valanor.co
+49 (0) 711 16 44 6 83
Lindenspürstrasse 22, 70176 Stuttgart
